Wilson Sonsini Goodrich & Rosati advised Amber on the transaction. Amber Therapeutics, a UK-based medical technology company, announced it closed a Series A financing, raising $100...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here